LT4838B - 1,3,4-oksadiazolono dariniai - Google Patents

1,3,4-oksadiazolono dariniai Download PDF

Info

Publication number
LT4838B
LT4838B LT2000068A LT2000068A LT4838B LT 4838 B LT4838 B LT 4838B LT 2000068 A LT2000068 A LT 2000068A LT 2000068 A LT2000068 A LT 2000068A LT 4838 B LT4838 B LT 4838B
Authority
LT
Lithuania
Prior art keywords
methyl
phenyl
chloro
trifluoromethyl
oxadiazol
Prior art date
Application number
LT2000068A
Other languages
English (en)
Lithuanian (lt)
Other versions
LT2000068A (en
Inventor
Piyasena Hewawasam
Min Ding
John E. Starrett
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of LT2000068A publication Critical patent/LT2000068A/xx
Publication of LT4838B publication Critical patent/LT4838B/lt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
LT2000068A 1998-01-29 2000-07-14 1,3,4-oksadiazolono dariniai LT4838B (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7296698P 1998-01-29 1998-01-29
US10227498P 1998-09-29 1998-09-29

Publications (2)

Publication Number Publication Date
LT2000068A LT2000068A (en) 2001-03-26
LT4838B true LT4838B (lt) 2001-08-27

Family

ID=26753969

Family Applications (1)

Application Number Title Priority Date Filing Date
LT2000068A LT4838B (lt) 1998-01-29 2000-07-14 1,3,4-oksadiazolono dariniai

Country Status (27)

Country Link
US (1) US6034113A (id)
EP (1) EP1051173A4 (id)
JP (1) JP2002527352A (id)
KR (1) KR20010077838A (id)
CN (1) CN1150175C (id)
AR (1) AR010712A1 (id)
AU (1) AU735704B2 (id)
BG (1) BG104706A (id)
BR (1) BR9913010A (id)
CA (1) CA2318830A1 (id)
CO (1) CO5090837A1 (id)
EE (1) EE04089B1 (id)
GE (1) GEP20032914B (id)
HU (1) HUP0102025A3 (id)
ID (1) ID26909A (id)
IL (1) IL137518A0 (id)
LT (1) LT4838B (id)
LV (1) LV12559B (id)
NO (1) NO317102B1 (id)
NZ (1) NZ505409A (id)
PL (1) PL342060A1 (id)
RU (1) RU2202548C2 (id)
SK (1) SK10852000A3 (id)
TR (1) TR200002019T2 (id)
TW (1) TW550075B (id)
UA (1) UA58579C2 (id)
WO (1) WO1999038510A1 (id)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU736599B2 (en) * 1998-01-29 2001-08-02 Bristol-Myers Squibb Company Amino acid derivatives of diaryl 1,3,4-oxadiazolone
US6297241B1 (en) 1999-01-29 2001-10-02 Bristol-Myers Squibb Company Carbamate derivatives of diaryl 1,3,4-oxadiazolone
US6162817A (en) * 1999-01-29 2000-12-19 Bristol-Myers Squibb Company Carbamate derivatives of diaryl 1,3,4-oxadiazolone
US6326388B1 (en) * 1999-12-21 2001-12-04 Celgene Corporation Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level
MXPA03007397A (es) 2001-02-20 2003-12-04 Bristol Myers Squibb Co Moduladores de canales de potasio kcnq y uso de los mismos en tratamiento de migrana y enfermedades mecanicamente relacionadas.
CN100540538C (zh) * 2001-04-16 2009-09-16 田边三菱制药株式会社 高传导率钙-活化k通道开启剂
US6909027B1 (en) * 2001-08-13 2005-06-21 Perry Robins Method of forming an in-situ film dressing and the composition of the film-forming material
US7119246B2 (en) * 2002-06-25 2006-10-10 Perry Robins Method of treating acne
ES2969344T3 (es) 2012-01-18 2024-05-17 Techfields Pharma Co Ltd Composiciones de profármaco de alta penetración y composición farmacéutica del mismo para el tratamiento de afecciones pulmonares
JP5855599B2 (ja) * 2013-04-30 2016-02-09 テックフィールズ バイオケム カンパニー リミテッド 非常に速い皮膚浸透率を有するアセトアミノフェン及び関連化合物の正荷電水溶性プロドラッグ
CN104710379B (zh) * 2015-03-09 2017-01-18 华南理工大学 一种bms‑191011的合成方法
JP6165816B2 (ja) * 2015-10-01 2017-07-19 テックフィールズ バイオケム カンパニー リミテッド 非常に速い皮膚浸透率を有するアセトアミノフェン及び関連化合物の正荷電水溶性プロドラッグ
AU2018225758A1 (en) * 2017-02-24 2019-09-05 Ovid Therapeutics Inc. Methods of treating seizure disorders
US12194026B2 (en) 2018-10-26 2025-01-14 University Of South Florida Drug for treating tinnitus
CN110987847B (zh) * 2019-12-11 2021-02-19 苏州今蓝纳米科技有限公司 1,3,4-噁二唑衍生物在检测酸以及数据加密和储存中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3971803A (en) 1973-05-21 1976-07-27 Ciba-Geigy Corporation 3-Hydroxybenzyl-oxadiazolone and -thiadiazolone derivatives
WO1998004135A1 (en) 1996-07-31 1998-02-05 Bristol-Myers Squibb Company Diphenyl heterocycles as potassium channel modulators

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1251488B (it) * 1991-09-17 1995-05-15 Mini Ricerca Scient Tecnolog Ossa(tia)diazol- e triazol-oni(tioni) ad attivita' acaricida ed insetticida
US5234947A (en) * 1991-11-07 1993-08-10 New York University Potassium channel activating compounds and methods of use thereof
US5547966A (en) * 1993-10-07 1996-08-20 Bristol-Myers Squibb Company Aryl urea and related compounds
AU736599B2 (en) * 1998-01-29 2001-08-02 Bristol-Myers Squibb Company Amino acid derivatives of diaryl 1,3,4-oxadiazolone

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3971803A (en) 1973-05-21 1976-07-27 Ciba-Geigy Corporation 3-Hydroxybenzyl-oxadiazolone and -thiadiazolone derivatives
WO1998004135A1 (en) 1996-07-31 1998-02-05 Bristol-Myers Squibb Company Diphenyl heterocycles as potassium channel modulators

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
NIGEL S. COOK: "The pharmacology of potassium channels and their therapeutic potential", TRENDS IN PHARMACOLOGICAL SCIENCES, 1988, pages 21 - 28
TRIVEDI S ET AL.: "Calcium dependent K-channels in guinea pig and human urinary bladder", BIOCHEM BIOPHYS RES COMMUN., 1995, pages 404 - 409
ULRICH QUAST , NIGEL S. COOK: "Moving together: K+ channel openersand ATP-sensitive K+ channels", TRENDS IN PHARMACOLOGICAL SCIENCES, 1989, pages 431 - 435
WILDER SMITH, A.E.: "Preparation of Some New 4-Substituted Derivatives of p-Amino-o-hydroxy-phenyl-1,3,4-oxadiazolone-5 and Study of their Mycobacteriostatic Activity", ARZNEIM. FORSCH., 1967, pages 768 - 772

Also Published As

Publication number Publication date
LV12559A (en) 2000-11-20
BG104706A (en) 2001-04-30
KR20010077838A (ko) 2001-08-20
PL342060A1 (en) 2001-05-21
LV12559B (en) 2001-04-20
EE04089B1 (et) 2003-08-15
TR200002019T2 (tr) 2000-11-21
NO20003825D0 (no) 2000-07-26
TW550075B (en) 2003-09-01
CO5090837A1 (es) 2001-10-30
LT2000068A (en) 2001-03-26
UA58579C2 (uk) 2003-08-15
CN1150175C (zh) 2004-05-19
US6034113A (en) 2000-03-07
GEP20032914B (en) 2003-03-25
EE200000447A (et) 2001-12-17
AU2230899A (en) 1999-08-16
RU2202548C2 (ru) 2003-04-20
SK10852000A3 (sk) 2002-02-05
ID26909A (id) 2001-02-15
HUP0102025A2 (hu) 2001-11-28
JP2002527352A (ja) 2002-08-27
EP1051173A4 (en) 2002-07-31
CN1289249A (zh) 2001-03-28
NO317102B1 (no) 2004-08-09
HUP0102025A3 (en) 2002-01-28
IL137518A0 (en) 2001-07-24
CA2318830A1 (en) 1999-08-05
NO20003825L (no) 2000-07-26
BR9913010A (pt) 2001-05-08
NZ505409A (en) 2003-08-29
AU735704B2 (en) 2001-07-12
WO1999038510A1 (en) 1999-08-05
EP1051173A1 (en) 2000-11-15
AR010712A1 (es) 2000-07-12

Similar Documents

Publication Publication Date Title
RU2202548C2 (ru) Производные 1,3,4-оксадиазолона, фармацевтическая композиция на их основе и способ лечения
US5939405A (en) Phosphate derivatives of diaryl 1,3,4-oxadiazolone
US5948802A (en) Benzoate derivatives of diaryl 1,3,4-oxadiazolone
US5977150A (en) Amino acid derivatives of diaryl 1,3,4-oxadiazolone
US6162817A (en) Carbamate derivatives of diaryl 1,3,4-oxadiazolone
US6297241B1 (en) Carbamate derivatives of diaryl 1,3,4-oxadiazolone
CZ20002647A3 (cs) Deriváty 1,3,4-oxadiazolonu

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 20050115